ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 316158 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 316158; 2) Community: the network communities that were significantly associated with the response to NSC 316158; 3) Molecule: the relationships between components within communities and NSC 316158; 4) MDR: the compounds that were significantly associated with the NSC 316158.

NSC Compound Enrichment Correlation
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0139796580235792 0.351311
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0139796580235792 0.31790462
NSC 244404 Null 0.0139796580235792 0.24820486
NSC 303861 L-Cysteine analog 0.0139796580235792 0.19801544
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0139796580235792 0.25602077
NSC 339137 PHYSALOLACTONE 0.0139796580235794 0.26174978
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0139796580235794 0.27010672
NSC 371777 Null 0.0139796580235794 0.33054831
NSC 372155 2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- 0.0139796580235794 0.067911864
NSC 603578 Platinum, tetrachloro[dimethylsilylenebis(methanamine)]-, (OC-6-22) 0.0139796580235794 0.25896011
Total:87  Current:32    [First] [Prev] [Next] [Last]